Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2019
Reporting Period: The filing reports on a specific corporate event occurring on March 1, 2019, regarding the amendment of warrant expiration dates.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a material definitive agreement regarding warrant terms.
Material Changes
The primary material change reported is the extension of the expiration date for specific warrant classes:
- Warrant Classes Affected: Class N Warrants and Class O Warrants.
- Previous Expiration Date: March 17, 2019.
- New Expiration Date: June 28, 2019.
- Effective Date: March 1, 2019.
- Notification: Holders were notified via a letter dated March 14, 2019.
Guidance, Outlook, and Related Parties
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the warrant extension.
Related Party Involvement: The filing discloses that certain Class O Warrants are held by members of the Board of Directors (Kevin Richardson, John Nemelka, Alan Rubino, Michael Stolarski, and Maj-Britt Kaltoft) and the Controller/Chief Financial Officer (Lisa Sundstrom).
Investor Verification Checklist
- Verify the full text of the Warrant Extension Letter (Exhibit 4.2) for specific terms and conditions not detailed in the summary.
- Review the forms of the Class N and Class O Warrants (Exhibit 4.1) to understand the rights and obligations associated with the extended expiration date.
- Confirm the impact of the extension on the company's capital structure and potential future dilution.
- Check for any subsequent filings regarding the exercise or expiration of these warrants by the new June 28, 2019 deadline.